Table 1—

Clinical characteristics of subjects

2-h plasma glucose (mmol/l) after OGTT
P
NGT (n = 51)
IGT (n = 15)
gr.I (<5.6)gr.II (5.6–6.7)gr.III (6.7–7.8)gr.IV (7.8–11.1)
Sex (female/male)5/1012/118/56/9NS
Age (years)32.2 ± 1.234.1 ± 1.836.2 ± 2.945.1 ± 1.4*<0.0001
BMI (kg/m2)21.7 ± 0.923.1 ± 0.925.6 ± 1.0*27.2 ± 0.8*<0.0001
Waist circumference (cm)74.9 ± 2.775.6 ± 2.481.4 ± 2.691.8 ± 2.8*<0.0001
Glucose infusion rate (mg · kgFFM−1 · min−1)9.31 ± 0.829.43 ± 0.717.49 ± 0.516.04 ± 0.67*0.004
HOMA%B127.9 ± 6.9116.0 ± 8.6129.0 ± 13.7124.0 ± 12.2NS
HOMA%Badjusted1150.9 ± 89.21012.2 ± 67.8951.1 ± 111.1690.9 ± 73.4*0.005
  • Data are means ± SE. HOMA%Badjusted= HOMA%B × glucose infusion rate.

  • * P < 0.05 compared with gr.I;

  • P < 0.05 compared with gr.II;

  • P < 0.05 compared with gr.III. IGT, impaired glucose tolerance; OGTT, oral glucose tolerance test.